Cardioprotection of controlled and cardiac-specific over-expression of a2A-adenosine receptor in the pressure overload

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Hamad, Eman A ^a,b   Zhu, Weizhong ^a   Chan, Tung O ^b   Myers, Valerie ^a   Gao, Erhe ^a   Li, Xue ^b   Zhang, Jin ^b   Song, Jianliang ^a   Zhang, Xue Qian ^a   Cheung, Joseph Y ^a   Koch, Walter ^a   Feldman, Arthur M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; ATRIAL NATRIURETIC FACTOR; COMPLEMENT COMPONENT C3; CYSTEINE DIOXYGENASE; MESSENGER RNA; MYOSIN HEAVY CHAIN BETA; TRANSCRIPTION FACTOR GATA 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRIAL NATRIURETIC FACTOR GENE; BETA MYOSIN HEAVY CHAIN GENE; BODY WEIGHT; COMPLEMENT COMPONENT 3 GENE; CONTROLLED STUDY; CYSTEINE DIOXYGENASE GENE; ELECTROCARDIOGRAPHY; GENE; GENE EXPRESSION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART STRESS; HEART WEIGHT; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SERINE PEPTIDASE INHIBITOR MEMBER 3N GENE; SIGNAL TRANSDUCTION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CALCIUM; DISEASE MODELS, ANIMAL; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN SPECIFICITY; RECEPTORS, ADENOSINE A2;

MUS;

EID: 84863640634     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039919     Document Type: Article

References (54)

1. Headrick JP HB, Ashton KJ, (2003) Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol Heart Circ Physiol 285: H1797-H1818.
2. Sullivan GW RJ, Scheld WM, Macdonald TL, Linden J, (2001) Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. Br J Pharmacol 132: 1017-1026.
3. Dobson JG Jr, Fenton RA, (1997) Adenosine A2 receptor function in rat ventricular myocytes. Cardiovasc Res 34: 337-347.
4. Headrick JP WL, Ashton KJ, Holmgren K, Peart J, Matherne GP (2003) Ischaemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression. J of physiol 549 (pt 3): 823-833.
5. Safran N SV, Balas N, Jacobson KA, Nawrath H, Shainberg A, (2001) Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes. Mol Cell Biochem 217: 14.
6. Todd J, Zhao ZQ, Williams MW, Sato H, Van Wylen DG, et al. (1996) Intravascular adenosine at reperfusion reduces infarct size and neutrophil adherence. Ann Thorac Surg 62: 1364-1372.
7. Vinten-Johansen J, Thourani VH, Ronson RS, Jordan JE, Zhao ZQ, et al. (1999) Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg 68: 1942-1948.
8. Dubey RK, Gillespie DG, Mi Z, Jackson EK, (1997) Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: role of A2B receptors. Circulation 96: 2656-2666.
9. Wagner DR, McTiernan C, Sanders VJ, Feldman AM, (1998) Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha in the failing human heart. Circulation 97: 521-524.
10. Chung ES, Perlini S, Aurigemma GP, Fenton RA, Dobson JG Jr, et al. (1998) Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. J Hypertens 16: 1813-1822.
11. Liao Y, Takashima S, Asano Y, Asakura M, Ogai A, et al. (2003) Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model. Circ Res 93: 759-766.
12. Gan XT, Rajapurohitam V, Haist JV, Chidiac P, Cook MA, et al. (2005) Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes. J Pharmacol Exp Ther 312: 27-34.
13. Xu X, Fassett J, Hu X, Zhu G, Lu Z, et al. (2008) Ecto-5′-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction. Hypertension 51: 1557-1564.
14. Lu Z, Fassett J, Xu X, Hu X, Zhu G, et al. (2008) Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle. Circulation 118: 1713-1721.
15. Funakoshi H, Chan TO, Good JC, Libonati JR, Piuhola J, et al. (2006) Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function. Circulation 114: 2240-2250.
16. Hunter JJ, Chien KR, (1999) Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341: 1276-1283.
17. Jessup M, Brozena S, (2003) Heart failure. N Engl J Med 348: 2007-2018.
18. Harada K, Sugaya T, Murakami K, Yazaki Y, Komuro I, (1999) Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation 100: 2093-2099.
19. Gajewski K, Fossett N, Molkentin JD, Schulz RA, (1999) The zinc finger proteins Pannier and GATA4 function as cardiogenic factors in Drosophila. Development 126: 5679-5688.
20. Amedeo Modesti P, Zecchi-Orlandini S, Vanni S, Polidori G, Bertolozzi I, et al. (2002) Release of preformed Ang II from myocytes mediates angiotensinogen and ET-1 gene overexpression in vivo via AT1 receptor. J Mol Cell Cardiol 34: 1491-1500.
21. Sanbe A, Gulick J, Hanks MC, Liang Q, Osinska H, et al. (2003) Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ Res 92: 609-616.
22. Hamad EA, Li X, Song J, Zhang XQ, Myers V, et al. (2010) Effects of cardiac-restricted overexpression of the A(2A) adenosine receptor on adriamycin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol 298: H1738-1747.
23. Chan TO, Funakoshi H, Song J, Zhang XQ, Wang J, et al. (2008) Cardiac-restricted overexpression of the A(2A)-adenosine receptor in FVB mice transiently increases contractile performance and rescues the heart failure phenotype in mice overexpressing the A(1)-adenosine receptor. Clin Transl Sci 1: 126-133.
24. Funakoshi H, Zacharia LC, Tang Z, Zhang J, Lee LL, et al. (2007) A1 adenosine receptor upregulation accompanies decreasing myocardial adenosine levels in mice with left ventricular dysfunction. Circulation 115: 2307-2315.
25. Xia Y, Lee K, Li N, Corbett D, Mendoza L, et al. (2009) Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem Cell Biol 131: 471-481.
26. Nagai T, Anzai T, Kaneko H, Mano Y, Anzai A, et al. (2011) C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response. Hypertension 57: 208-215.
27. Higuchi Y, Chan TO, Brown MA, Zhang J, DeGeorge BR Jr, et al. (2006) Cardioprotection afforded by NF-kappaB ablation is associated with activation of Akt in mice overexpressing TNF-alpha. Am J Physiol Heart Circ Physiol 290: H590-598.
28. Hasko G, Pacher P, (2008) A2A receptors in inflammation and injury: lessons learned from transgenic animals. J Leukoc Biol 83: 447-455.
29. Impellizzeri D, Di Paola R, Esposito E, Mazzon E, Paterniti I, et al. (2011) CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation. Eur J Pharmacol 668: 305-316.
30. Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman AL, et al. (2003) An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol 163: 711-721.
31. Grossman W, Jones D, McLaurin LP, (1975) Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56: 56-64.
32. Grossman W, McLaurin LP, Stefadouros MA, (1974) Left ventricular stiffness associated with chronic pressure and volume overloads in man. Circ Res 35: 793-800.
33. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA, (2006) Controversies in ventricular remodelling. Lancet 367: 356-367.
34. Harris DE, Work SS, Wright RK, Alpert NR, Warshaw DM, (1994) Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro. J Muscle Res Cell Motil 15: 11-19.
35. Holubarsch C, Goulette RP, Litten RZ, Martin BJ, Mulieri LA, et al. (1985) The economy of isometric force development, myosin isoenzyme pattern and myofibrillar ATPase activity in normal and hypothyroid rat myocardium. Circ Res 56: 78-86.
36. Holubarsch C, Litten RZ, Mulieri LA, Alpert NR, (1985) Energetic changes of myocardium as an adaptation to chronic hemodynamic overload and thyroid gland activity. Basic Res Cardiol 80: 582-593.
37. Krenz M, Robbins J, (2004) Impact of beta-myosin heavy chain expression on cardiac function during stress. J Am Coll Cardiol 44: 2390-2397.
38. Dorn GW 2nd, Robbins J, Ball N, Walsh RA (1994) Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am J Physiol 267: H400-405.
39. Yan X, Schuldt AJ, Price RL, Amende I, Liu FF, et al. (2008) Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes. Am J Physiol Heart Circ Physiol 294: H1274-1281.
40. Charron F, Tsimiklis G, Arcand M, Robitaille L, Liang Q, et al. (2001) Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev 15: 2702-2719.
41. Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE, et al. (2001) The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 276: 30245-30253.
42. Diedrichs H, Chi M, Boelck B, Mehlhorn U, Schwinger RH, (2004) Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure. Eur J Heart Fail 6: 3-9.
43. Hall JL, Grindle S, Han X, Fermin D, Park S, et al. (2004) Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics 17: 283-291.
44. Yang D, Ma S, Tan Y, Li D, Tang B, et al. (2010) Adrenergic receptor blockade-induced regression of pressure-overload cardiac hypertrophy is associated with inhibition of the calcineurin/NFAT3/GATA4 pathway. Mol Med Report 3: 497-501.
45. Morimoto T, Hasegawa K, Wada H, Kakita T, Kaburagi S, et al. (2001) Calcineurin-GATA4 pathway is involved in beta-adrenergic agonist-responsive endothelin-1 transcription in cardiac myocytes. J Biol Chem 276: 34983-34989.
46. Morisco C, Seta K, Hardt SE, Lee Y, Vatner SF, et al. (2001) Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J Biol Chem 276: 28586-28597.
47. Saadane N, Alpert L, Chalifour LE, (1999) Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice. Br J Pharmacol 127: 1165-1176.
48. Csoka B, Nemeth ZH, Virag L, Gergely P, Leibovich SJ, et al. (2007) A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli. Blood 110: 2685-2695.
49. De Ponti C, Carini R, Alchera E, Nitti MP, Locati M, et al. (2007) Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages. J Leukoc Biol 82: 392-402.
50. Fiser SM, Tribble CG, Kaza AK, Long SM, Kern JA, et al. (2002) Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion. J Thorac Cardiovasc Surg 124: 973-978.
51. McPherson JA, Barringhaus KG, Bishop GG, Sanders JM, Rieger JM, et al. (2001) Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler Thromb Vasc Biol 21: 791-796.
52. Okusa MD, Linden J, Macdonald T, Huang L, (1999) Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol 277: F404-412.
53. Most P SH, Gao E, Funakoshi H, Volkers M, Heierhorst J, et al. (2006) Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction. Circulation 114: 1258-1268.
54. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.